Discover 1,924 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,924
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
for
Chickenpox
Location: Miami FL, Hialeah FL, Lafayette LA, Richmond VA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06693895
Phase3, Recruiting
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
for
Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Location: Miami FL, Atlanta GA, Simpsonville SC, Spartanburg SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1 - 6
Code: NCT07406360
Phase3, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Miami Lakes FL, Miami FL, Tampa FL, Spring Hill FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06740630
Phase3, Recruiting
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Miami Lakes FL, Coral Gables FL, Tampa FL, Richmond VA,
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)